---
title: "Idelalisib - Leukemia, Lymphocytic, Chronic, B-Cell"
sidebar: mydoc_sidebar
permalink: idelalisibleukemialymphocyticchronicbcell.html
toc: false 
---

{% include image.html url="images/idelalisibleukemialymphocyticchronicbcell.png" file="idelalisibleukemialymphocyticchronicbcell.png" alt="idelalisibleukemialymphocyticchronicbcell" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C552946 | Idelalisib | Drug |
| UniProt:O00329 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Protein |
| REACT:R-HSA-109704 | PI3K Cascade | Pathway |
| GO:0042100 | B cell proliferation | BiologicalProcess |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Idelalisib | DECREASES ACTIVITY OF | Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta Isoform |
| Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta Isoform | PARTICIPATES IN | Pi3K Cascade |
| Pi3K Cascade | POSITIVELY REGULATES | B Cell Proliferation |
| B Cell Proliferation | POSITIVELY CORRELATED WITH | Leukemia, Lymphocytic, Chronic, B-Cell |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB09054#mechanism-of-action](https://go.drugbank.com/drugs/DB09054#mechanism-of-action){:target="_blank"}